Analysed DIAMEDICA THERAPEUTICS INC (DMAC:NASDAQ) News Sources
DiaMedica Therapeutics Announces First Patients Dosed in Phase 2 Trial of DM199 for the Treatment of Fetal Growth Restriction
23-06-2026
yahoo.com
DiaMedica Therapeutics Inc (DMAC) (Q2 2026) Earnings Call Highlights: Promising Preeclampsia ...
11-08-2026
yahoo.com
Wall Street Analysts Think DiaMedica Therapeutics (DMAC) Could Surge 129.97%: Read This Before Placing a Bet
26-08-2026
yahoo.com
What is the current price of DIAMEDICA THERAPEUTICS INC (DMAC:NASDAQ)?
The current price of DIAMEDICA THERAPEUTICS INC (DMAC:NASDAQ) is $6.53.
DIAMEDICA THERAPEUTICS INC (DMAC:NASDAQ) absolute price change since previous trading day?
The absolute price change of DIAMEDICA THERAPEUTICS INC (DMAC:NASDAQ) since the previous trading day is $0.06.
DIAMEDICA THERAPEUTICS INC (DMAC:NASDAQ) percentage price change since previous trading day?
The percentage price change of DIAMEDICA THERAPEUTICS INC (DMAC:NASDAQ) since the previous trading day is 0.9274%.
What is the most recent average sentiment score for DIAMEDICA THERAPEUTICS INC (DMAC:NASDAQ)?
The most recent average sentiment score for DIAMEDICA THERAPEUTICS INC (DMAC:NASDAQ) is 71 out of 100.
What is the most recent average sentiment for DIAMEDICA THERAPEUTICS INC (DMAC:NASDAQ)?
The most recent sentiment for DIAMEDICA THERAPEUTICS INC (DMAC:NASDAQ) is .
SEC-8K** Filing Available For DIAMEDICA THERAPEUTICS INC (DMAC:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.